Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Upcoming)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons
Yan Rao, … , Tamas L. Horvath, Xiao-Bing Gao
Yan Rao, … , Tamas L. Horvath, Xiao-Bing Gao
Published December 3, 2007
Citation Information: J Clin Invest. 2007;117(12):4022-4033. https://doi.org/10.1172/JCI32829.
View: Text | PDF
Research Article

Prolonged wakefulness induces experience-dependent synaptic plasticity in mouse hypocretin/orexin neurons

  • Text
  • PDF
Abstract

Sleep is a natural process that preserves energy, facilitates development, and restores the nervous system in higher animals. Sleep loss resulting from physiological and pathological conditions exerts tremendous pressure on neuronal circuitry responsible for sleep-wake regulation. It is not yet clear how acute and chronic sleep loss modify neuronal activities and lead to adaptive changes in animals. Here, we show that acute and chronic prolonged wakefulness in mice induced by modafinil treatment produced long-term potentiation (LTP) of glutamatergic synapses on hypocretin/orexin neurons in the lateral hypothalamus, a well-established arousal/wake-promoting center. A similar potentiation of synaptic strength at glutamatergic synapses on hypocretin/orexin neurons was also seen when mice were sleep deprived for 4 hours by gentle handling. Blockade of dopamine D1 receptors attenuated prolonged wakefulness and synaptic plasticity in these neurons, suggesting that modafinil functions through activation of the dopamine system. Also, activation of the cAMP pathway was not able to further induce LTP at glutamatergic synapses in brain slices from mice treated with modafinil. These results indicate that synaptic plasticity due to prolonged wakefulness occurs in circuits responsible for arousal and may contribute to changes in the brain and body of animals experiencing sleep loss.

Authors

Yan Rao, Zhong-Wu Liu, Erzsebet Borok, Rebecca L. Rabenstein, Marya Shanabrough, Min Lu, Marina R. Picciotto, Tamas L. Horvath, Xiao-Bing Gao

×

Figure 6

LTP of glutamatergic synapses on hypocretin/orexin neurons elicited by application of forskolin.

Options: View larger image (or click on image) Download as PowerPoint
LTP of glutamatergic synapses on hypocretin/orexin neurons elicited by a...
(A) Sample traces (left) and single events (right) of mEPSCs recorded in hypocretin/orexin neurons before and 30 minutes after the application of forskolin. (B) Time course of the averaged frequency of mEPSCs from all tested neurons is shown on the left, and pooled data of the frequency of mEPSCs from all neurons before and 30 minutes after the application of forskolin are shown on the right. **P < 0.01. (C) Time course of the averaged amplitude of mEPSCs recorded in our experiments is shown on the left. Right: Cumulative probability of mEPSC amplitude recorded before (831 events) and 30 minutes after the application of forskolin (1,566 events) (P < 0.001, Kolmogorov-Smirnov test). (D) LTP of the frequency of mEPSCs induced by forskolin is intact in the presence of PKI6-22 in the pipette solution. Left: Time course of mEPSC frequency during the postsynaptic application of PKI6-22. Right: Pooled data of mEPSC frequency from all tested neurons before and 30 minutes after the application of forskolin. **P < 0.01, paired Student’s t test. (E) LTP of mEPSC amplitude is blocked when PKI6-22 is present in pipette solution. Left: Time course of mEPSC amplitude recorded in our experiments during the postsynaptic application of PKI6-22. Right: Cumulative probability of mEPSC amplitude recorded before (469 events) and 30 minutes after the application of forskolin (1,100 events) when PKI6-22 was applied to postsynaptic neurons (P > 0.05, Kolmogorov-Smirnov test).

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts